Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

SELL
$92.52 - $104.91 $846,465 - $959,821
-9,149 Reduced 80.79%
2,175 $219,000
Q1 2023

Apr 21, 2023

BUY
$80.03 - $92.81 $133,890 - $155,271
1,673 Added 17.33%
11,324 $1.04 Million
Q4 2022

Jan 17, 2023

SELL
$75.55 - $92.52 $149,060 - $182,541
-1,973 Reduced 16.97%
9,651 $0
Q3 2022

Nov 01, 2022

BUY
$74.61 - $87.26 $5,670 - $6,631
76 Added 0.66%
11,624 $884,000
Q2 2022

Jul 25, 2022

SELL
$80.52 - $93.75 $466,854 - $543,562
-5,798 Reduced 33.43%
11,548 $976,000
Q1 2022

Apr 27, 2022

BUY
$80.11 - $90.62 $612,440 - $692,789
7,645 Added 78.81%
17,346 $1.52 Million
Q4 2021

Jan 20, 2022

SELL
$79.7 - $88.13 $202,916 - $224,378
-2,546 Reduced 20.79%
9,701 $849,000
Q3 2021

Oct 15, 2021

BUY
$81.78 - $95.14 $16,356 - $19,028
200 Added 1.66%
12,247 $1 Million
Q2 2021

Jul 14, 2021

BUY
$85.24 - $94.15 $144,055 - $159,113
1,690 Added 16.32%
12,047 $1.1 Million
Q1 2021

Apr 20, 2021

BUY
$83.5 - $98.47 $4,342 - $5,120
52 Added 0.5%
10,357 $885,000
Q4 2020

Jan 29, 2021

SELL
$78.07 - $94.43 $8,587 - $10,387
-110 Reduced 1.06%
10,305 $973,000
Q3 2020

Oct 15, 2020

BUY
$82.14 - $91.0 $310,653 - $344,162
3,782 Added 57.02%
10,415 $906,000
Q2 2020

Jul 14, 2020

SELL
$80.93 - $91.1 $138,633 - $156,054
-1,713 Reduced 20.52%
6,633 $579,000
Q1 2020

Apr 23, 2020

SELL
$70.67 - $99.01 $93,213 - $130,594
-1,319 Reduced 13.65%
8,346 $688,000
Q4 2019

Feb 11, 2020

BUY
$84.35 - $95.37 $138,755 - $156,883
1,645 Added 20.51%
9,665 $915,000
Q3 2019

Nov 12, 2019

BUY
$85.54 - $94.26 $408,795 - $450,468
4,779 Added 147.45%
8,020 $697,000
Q2 2019

Aug 09, 2019

BUY
$75.4 - $92.8 $27,144 - $33,408
360 Added 12.5%
3,241 $296,000
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $37,132 - $42,471
493 Added 20.64%
2,881 $277,000
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $175,900 - $195,863
2,388 New
2,388 $205,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.